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delivery to the poor and disadvantaged
more expensive than it currently was.
Earlier Maureen Kirkman, head of
scientific and regulatory affairs at the
Pharmaceutical Manufacturers
Association, warned that the impending
amendments had already resulted in
'perverse but probably legal' new
methods of marketing and selling
drugs.
Among the methods that stood to
negate the good intentions of the new
law were retainer fees paid to doctors
for 'information', payment for 'shelf
space' in stores (and pharmacies), and
payment of 'listing fees' to get products
onto medical aid formularies.
Retailers were also threatening to
treat medicines as 'consignment stocks'.
Kirkman confirmed Letlape's
contention that drugs stood to cost more
for the very people that the new law
sought to help.
Chris Bateman
The plethora of problems confronting
doctors in the current socio-political
environment was a clarion call to
mobilise into a single collective unit in
order to survive and deliver vital health
care to patients, says SAMA's new
Secretary-General, Dr Moji Mogari.
Mogari, a graduate of Zululand, Cape
Town and Medunsa with 8 years’
experience in general medical practice,
said however, that his first priority
would be to 'stabilise' SAMA's
administration and help staff 'to settle
down' after 21 tumultuous months.
He was referring to the hiatus in top
management since his predecessor, Dr
Percy Mahlati, resigned in December
2001, leaving SAMA chairman, Dr Kgosi
Letlape, and senior administrator,
Braam Volschenk, running the
organisation.
Mahlati, whose acrimonious parting
with SAMA was marked by a forensic
audit and mutual finger pointing within
the executive, is now senior advisor in
the office of the national Director-
General of Health.
Mogari sees his own appointment as
a healthy thing — 'to bring in a person
who will focus on the business of the
association'.
'For nearly 2 years SAMA has been
very visibly and vociferously dealing
with legislation, HIV/AIDS and the
quality and conditions of employment
of public sector doctors.'
‘However we had a 35% staff
turnover and membership plateaued
out at 16 000.’
Mogari, whose background includes
founding Philani Healthcare and
merging it with Prime Cure, doubling
monthly turnover in 14 months,
believes doctors became disillusioned
with SAMA for its lack of visibility, lack
of transformation and internal politics.
When Mahlati, who was prominent in
apartheid-era medical politics, left
SAMA, many senior black managers
followed.
'And make no mistake, many black
doctors left the association as well,'
Mogari added.
Mogari said Letlape's single biggest
achievement had been 'to unify the
association along colour lines' since
then.
Letlape had succeeded in getting
doctors to see the merit of continuing
with a single unified medical
association.
'I want to take that vision forward
and ensure that the association plays a
slightly more prominent role in the day-
to-day business of being medical
doctors,' Mogari said.
He said his outspoken
ophthalmologist chairman had been
circumstantially unable to pay adequate
attention to the business of the
association. Others who were not
medically qualified could ‘never run the
medical association [as] doctors need a
colleague', he said.
Letlape's lengthy period of playing a
dual role as chairman and CEO was
widely seen as undesirable by members.
If a feature of Letlape's chairmanship
has been to play 'bad cop' to the
government’s recalcitrance around
health issues, Mogari seems well set to
play the 'good cop'.
'I tend to avoid unnecessary conflict
— I try to get consensus wherever I can.
My style of management is to deal with
the most hostile people by being less
hostile myself and bringing them closer.
I believe in functioning as a team.'
Mogari wants to 'build and facilitate,
despite our differences with the
minister. I want to re-establish that link
between the Medical Association and
the Department of Health.'
Ironically one of the officials he will
have to deal with most will be Percy
Mahlati. Asked how he would cope
with Letlape's combative style, Mogari
said he would 'not give up — I've met
the minister (Tshabalala-Msimang) and 
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her husband Mendi (ANC Treasurer-
General and former South African
Ambassador to Britain) separately at
informal occasions.’
'When you get beyond the HIV/AIDS
line, she is a lovely person; I call him
‘Bra Mendi’ and her ‘Aunty,' he
revealed.
Mogari attended the same medical
school with Gwen Ramakgoba
(Gauteng Health MEC) and Molefi
Sefularo (North West Health MEC) and
has 'good relationships' with them.
While SAMA would continue to
highlight legislative issues affecting
doctors, 'we are committed to become
an integral part of the health care
delivery system in partnership with the
government'.
He said SAMA's actions should 'not
be viewed in a negative light, but as a
way of highlighting the issues to a
public that is not fully informed'.
Mogari, who completed a Wits
Business School certificate programme
in finance and accounting cum laude
emphasised that the current problems
extended 'well beyond government' into 
the private sector and health care
funding.
Yet one of his first tests will be
enrolling government into using GPs
(who see over 50% of South Africa's
patients) as a vital platform for
dispensing antiretroviral drugs —
reliably learnt to be a key
recommendation of the cabinet AIDS
task team.
Whether the new 'good cop, bad cop'
team can pull that one off in the face of
'sloppy' new dispensing legislation
disadvantaging both patients and
doctors, remains to be seen.
Chris Bateman
South Africa's new drug pricing
committee, committed to 'dramatically'
slashing overall drug prices and putting
quality medicines within reach of many
more people, is under considerable time
pressure to complete the most difficult
and contentious chunk of its work.
Section 18A of the Medicines Control
Amendment Act, which prevents
anyone from supplying medicine via a
bonus system, rebate system or any
other incentive scheme, is due for
implementation on 2 May 2004.
According to the committee
chairperson, health economist Diane
McIntyre, some stakeholders feel that it
would be best if regulations arising
from the pricing committee's
recommendations came into effect at the
same time as Section 18A.
McIntyre emphasised that it was
'crucial' for all those involved in the
manufacture, distribution and
dispensing of medicines to recognise
that Section 18A is not part of the
pricing committee's terms of reference
and that it will come into effect on 2
May 2004 in terms of the 'Presidential
proclamation on this Act'. 
'We're under pressure to come up
with proposals and to have something
in place by the time this section kicks in.
Everyone agrees that the time frame is
short. But the bottom line is we'll pull
out all the stops to try to meet the
deadline.'
She did, however, say that she would
refuse to compromise if her committee
felt they were not in a position to put
forward sound and solid
recommendations.
‘If we can't defend and argue strongly
for our recommendations, we'll not
consider ourselves bound by this time
frame — at the end of the day we want
our recommendations to be based on
good information.’
The pricing committee's functions
include:
•The introduction of a transparent 
pricing system, including a single 
exit price for all medicines and 
scheduled substances. 
•Determination of an appropriate 
dispensing fee to be charged by 
pharmacists or any person licensed 
to dispense in terms of the Act. 
•Determination of an appropriate fee 
to be charged by the wholesalers or 
distributors or any person selling 
medicines that do not require 
prescription.  
At the time of the SAMJ interview (17
September) McIntyre indicated that she
was busy trying to establish from the
Ministry of Health when the
representatives from the Treasury and
Trade and Industry would be appointed
to her committee.
She said these members needed to be
on board before the committee could
come up with its recommendations. 
‘I'm confident that it will happen
quite quickly because everyone regards
this work as really important and
urgent. In the meantime we can collect
information and start doing some
thinking.’ She said all committee
members were appointed on the basis of
technical expertise. 
She appealled to doctors 'to
understand that it's going to be difficult
to have detailed consultations with
people before we put together our draft
recommendations'.  As evidence of the
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If a feature of Letlape's
chairmanship has been to play
'bad cop' to the government’s
recalcitrance around health
issues, Mogari seems well set
to play the 'good cop'.
DRUG PRICING: THE END OF THE GRAVY TRAIN?
